W22May 25 - May 31Opus 4.8 + a $65B raise, Devin at $492M ARR, and FDA drafting AI models into oncology guidance.Newsletter · 4 min readOpen
W21May 18 - May 24IsoDDE at 2x AF3, Co-Scientist validates hypotheses, MHRA proposes single-authorization pathwayNewsletter · 4 min readOpen
W20May 11 - May 17Anthropic + Gates $200M. Cerebras $60B IPO. FDA one-day inspections live. MHRA rewrites GB devices.Newsletter · 5 min readOpen
W19May 4 - May 10Anthropic stacks SpaceX + Akamai + Blackstone. FDA ships Elsa 4.0. First PROTAC clears. Utah pulls an AI doctor.Newsletter · 5 min readOpen
W18Apr 27 - May 3AGI clause is dead. FDA streams trial data live. Anthropic at $900B. PROTACs cleared.Newsletter · 4 min readOpen
W17Apr 20 - Apr 26Frontier cadence in weeks. Coverage in two months. AI overreliance now its own cGMP citation.Newsletter · 4 min readOpen
W16Apr 13 - Apr 19Opus 4.7 + Claude Design + Narasimhan board seat; FDA denies Harrison.ai; OpenAI ships GPT-Rosalind; AWS ships Amazon Bio Discovery.Newsletter · 5 min readOpen
W15Apr 6 - Apr 12Anthropic gated Mythos and bought Coefficient; OpenAI matched Claude Max at $100; MHRA opened a faster door.Newsletter · 4 min readOpen
W14Mar 30 - Apr 5Gemma 4 runs on a 4090. Skull bones deliver drugs to the brain. Anthropic launches Project Glasswing.Newsletter · 3 min readOpen
W13Mar 23 - Mar 29iPSC therapies go clinical in Japan. Anthropic ships auto mode and Stripe launches CLI-first agent provisioning.Newsletter · 3 min readOpen
W12Mar 16 - Mar 22Two first-in-class FDA approvals, Cursor's Composer 2, OpenAI acquires Astral, and the White House AI framework.Newsletter · 3 min readOpen
W11Mar 9 - Mar 15Rentosertib proved AI can find drugs that work. NVIDIA shipped 7 chips to 10x inference.Newsletter · 3 min readOpen
W10Mar 2 - Mar 8GPT-5.4 exceeded the OSWorld human baseline. CAR-T finds hidden tumor targets. FDA merges 7 safety databases.Newsletter · 3 min readOpen
W09Feb 23 - Mar 1Gemini 3.1, Claude Sonnet 4.6, GPT-5.3-Codex all dropped this week. So did QMSR. And eyonis LCS.Newsletter · 3 min readOpen
W08Feb 16 - Feb 22Sonnet 4.6 and Gemini 3.1 both hit record benchmarks at mid-tier pricing; QMSR took effect; frontier models added medical features with no regulatory infrastructure.Newsletter · 4 min readOpen
W07Feb 9 - Feb 15OpenAI warned lawmakers about DeepSeek. FDA's 30-year QSR ended. Here's what both mean for builders.Newsletter · 4 min readOpen
W06Feb 2 - Feb 8Anthropic and OpenAI raced each other to agentic coding. FDA replaced a 30-year-old regulation. Both happened the same week.Newsletter · 4 min readOpen
W05Jan 26 - Feb 1DeepSeek R1 matched o1 at 27x lower cost. FDA replaced 30 years of inspection protocol. Both in the same week.Newsletter · 5 min readOpen
W04Jan 19 - Jan 25Anthropic published a 23,000-word Claude Constitution. A jury will decide OpenAI's founding promise. FDA's January package became the record.Newsletter · 5 min readOpen
W03Jan 12 - Jan 18DeepSeek dropped o1-class reasoning for free. FDA dropped premarket review for 40 digital health devices. Both in the same week.Newsletter · 4 min readOpen
W02Jan 5 - Jan 11NVIDIA cut inference costs 10x. FDA cut premarket barriers for CDS tools. Both on the same seven days.Newsletter · 4 min readOpen
W01Dec 29 - Jan 4DeepSeek R1 matched OpenAI o1 under MIT license. FDA and EMA published joint AI principles. Both happened in the same week.Newsletter · 4 min readOpen